MARKER THERAPEUTICS INC earnings per share and revenue

GX1 earnings per share for the last quarter are -0.23 EUR whereas the estimation was -0.35 EUR which accounts for 33.33% surprise. Company revenue for the same period amounts to 1.73 M EUR despite the estimated figure of 898.14 k EUR. Estimated earnings per share for the next quarter are -0.27 EUR, and revenue is expected to reach 965.20 k EUR. Also watch annual changes over time to get a bigger picture of GX1 earnings per share and revenue dynamics.